Today: Dec 22, 2024
RU / EN
Last update: Oct 30, 2024
The Appraisal of the Role of Biochemical Indices in Diagnostic Presentation of Metabolic Syndrome Using Discriminant Analysis

The Appraisal of the Role of Biochemical Indices in Diagnostic Presentation of Metabolic Syndrome Using Discriminant Analysis

Efremenko Y.R., Korolyova Е.F., Kontorshchikova К.N.
Key words: metabolic syndrome; discriminant analysis; oxidative stress.
2012, issue 4, page 85.

Full text

pdf
0
1602

The aim of the investigation is to assess the possibilities of discriminant analysis to determine the significance of some biochemical indices in metabolic syndrome development.

Materials and Methods. There were studied the biochemical parameters in blood plasma of 136 patients with metabolic syndrome and 50 virtually healthy people using standardized test systems. The findings were statistically processed by software package of statistical analysis R 2.11.0 and BIOSTAT.

Results. According to discriminant analysis of biochemical indices there was developed a prognostic model enabling to refer an experimental subject either to a group of patients with metabolic syndrome or to healthy people.
According to the analysis of discriminant functions there were determined variables that make a major contribution to pathogenic picture of metabolic syndrome and contain significant diagnostic information. Among these are: free cholesterol, the intensity of free radical oxidation, and the main products of oxidative protein modification. Thus, it can be argued that the important criteria in the development and progression of metabolic syndrome are both indicators of lipid metabolism, and indicators of oxidative stress.

  1. Grundy S.M. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007; 92(2): 399–404.
  2. Mancia G. et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–1187.
  3. Metabolicheskiy sindrom [Metabolic syndrome]. Pod red. Roytberg G.E. [Roytberg G.E. (editor)]. Moscow: MEDpress-inform; 2007; 224 p.
  4. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005; 365(9468): 1415–1428.
  5. Kuz’mina E.I., Nelyubin A.S., Shchennikova M.K. Biokhimiya i biofizika mikrobiologov — Biochemistry and Biophysics of Microbiologists 1983; 2: 41–48.
  6. Dubinina E.E., Burmistrov S.O., Khodov D.A., Porotov G.E. Voprosy meditsinskoy khimii — Medical Chemistry Issues 1995; 41(1): 24–26.
  7. Delarue J., Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 2007; 10(2): 142–148.
  8. Jialal I., Huet B.A., Kaur H., Chien A., Devaraj S. Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care 2012; 35(4): 900–904.
Efremenko Y.R., Korolyova Е.F., Kontorshchikova К.N. The Appraisal of the Role of Biochemical Indices in Diagnostic Presentation of Metabolic Syndrome Using Discriminant Analysis. Sovremennye tehnologii v medicine 2012; (4): 85


Journal in Databases

pubmed_logo.jpg

web_of_science.jpg

scopus.jpg

crossref.jpg

ebsco.jpg

embase.jpg

ulrich.jpg

cyberleninka.jpg

e-library.jpg

lan.jpg

ajd.jpg

SCImago Journal & Country Rank